A detailed history of Invesco Ltd. transactions in Liquidia Corp stock. As of the latest transaction made, Invesco Ltd. holds 25,231 shares of LQDA stock, worth $248,273. This represents 0.0% of its overall portfolio holdings.

Number of Shares
25,231
Previous 24,917 1.26%
Holding current value
$248,273
Previous $299,000 15.72%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$8.9 - $14.11 $2,794 - $4,430
314 Added 1.26%
25,231 $252,000
Q2 2024

Aug 13, 2024

SELL
$11.96 - $15.71 $5.2 Million - $6.83 Million
-434,485 Reduced 94.58%
24,917 $299,000
Q1 2024

May 14, 2024

BUY
$11.35 - $16.73 $4.76 Million - $7.02 Million
419,378 Added 1047.82%
459,402 $6.78 Million
Q4 2023

Feb 12, 2024

BUY
$5.77 - $12.19 $33,304 - $70,360
5,772 Added 16.85%
40,024 $481,000
Q3 2023

Nov 13, 2023

SELL
$6.27 - $8.15 $1.68 Million - $2.19 Million
-268,156 Reduced 88.67%
34,252 $217,000
Q2 2023

Aug 11, 2023

BUY
$6.63 - $9.9 $12,325 - $18,404
1,859 Added 0.62%
302,408 $2.37 Million
Q1 2023

May 12, 2023

BUY
$5.72 - $7.91 $1.56 Million - $2.16 Million
273,130 Added 996.13%
300,549 $2.08 Million
Q4 2022

Feb 13, 2023

BUY
$4.68 - $6.54 $15,556 - $21,738
3,324 Added 13.8%
27,419 $174,000
Q3 2022

Nov 14, 2022

SELL
$3.73 - $8.39 $23,573 - $53,024
-6,320 Reduced 20.78%
24,095 $131,000
Q2 2022

Aug 15, 2022

SELL
$3.37 - $7.55 $766,024 - $1.72 Million
-227,307 Reduced 88.2%
30,415 $133,000
Q1 2022

May 16, 2022

BUY
$5.14 - $7.38 $1.32 Million - $1.9 Million
257,722 New
257,722 $1.85 Million
Q4 2020

Feb 16, 2021

SELL
$2.6 - $5.79 $2.64 Million - $5.88 Million
-1,015,535 Closed
0 $0
Q3 2020

Nov 16, 2020

SELL
$4.34 - $8.28 $392,388 - $748,611
-90,412 Reduced 8.18%
1,015,535 $5 Million
Q2 2020

Aug 14, 2020

BUY
$4.86 - $11.44 $5.37 Million - $12.7 Million
1,105,947 New
1,105,947 $9.31 Million

Others Institutions Holding LQDA

About Liquidia Corp


  • Ticker LQDA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 64,362,300
  • Market Cap $633M
  • Description
  • Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension. It also distributes generic treprostinil inje...
More about LQDA
Track This Portfolio

Track Invesco Ltd. Portfolio

Follow Invesco Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Invesco Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Invesco Ltd. with notifications on news.